Summary
As the spread of COVID-19 outside China increased, consumers are interested in immunization. With the search for ways to strengthen the immune system, activities in this field are booming, especially vitamin C. In the past few months, the demand for immunity support products increased dramatically.
According to APO Research, The global Immunity Support Ingredients market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Immunity Support Ingredients is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Immunity Support Ingredients is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Immunity Support Ingredients is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Immunity Support Ingredients is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Immunity Support Ingredients include DSM, BASF, Zhejiang NHU, Croda, CSPC Pharma, EPAX, Adisseo, Zhejiang Medicine and Raisio Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Immunity Support Ingredients, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Immunity Support Ingredients, also provides the revenue of main regions and countries. Of the upcoming market potential for Immunity Support Ingredients, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunity Support Ingredients revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Immunity Support Ingredients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immunity Support Ingredients revenue, projected growth trends, production technology, application and end-user industry.
Immunity Support Ingredients segment by Company
DSM
BASF
Zhejiang NHU
Croda
CSPC Pharma
EPAX
Adisseo
Zhejiang Medicine
Raisio Group
Northeast Pharma
Shandong Luwei
Allied Biotech
Cargill
Anhui Tiger
Shandong Tianli
Kerry
Dohler
Kemin
Chenguang Biotech
FMC
Chr. Hansen
Excelvite
DDW
Immunity Support Ingredients segment by Type
Vitamin C
Vitamin E
Other Vitamins
Beta Glucans
Carotenoids
Phytosterols
Omega-3 Fatty Acids
Immunity Support Ingredients segment by Application
Nutrition Supplements
Foods & Beverages
Pharmaceuticals
Feeds
Pet Foods
Personal Care Products
Immunity Support Ingredients segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunity Support Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunity Support Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunity Support Ingredients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Immunity Support Ingredients in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Immunity Support Ingredients company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunity Support Ingredients revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Immunity Support Ingredients Market by Type
1.2.1 Global Immunity Support Ingredients Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Vitamin C
1.2.3 Vitamin E
1.2.4 Other Vitamins
1.2.5 Beta Glucans
1.2.6 Carotenoids
1.2.7 Phytosterols
1.2.8 Omega-3 Fatty Acids
1.3 Immunity Support Ingredients Market by Application
1.3.1 Global Immunity Support Ingredients Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Nutrition Supplements
1.3.3 Foods & Beverages
1.3.4 Pharmaceuticals
1.3.5 Feeds
1.3.6 Pet Foods
1.3.7 Personal Care Products
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Immunity Support Ingredients Market Dynamics
2.1 Immunity Support Ingredients Industry Trends
2.2 Immunity Support Ingredients Industry Drivers
2.3 Immunity Support Ingredients Industry Opportunities and Challenges
2.4 Immunity Support Ingredients Industry Restraints
3 Global Growth Perspective
3.1 Global Immunity Support Ingredients Market Perspective (2019-2030)
3.2 Global Immunity Support Ingredients Growth Trends by Region
3.2.1 Global Immunity Support Ingredients Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Immunity Support Ingredients Market Size by Region (2019-2024)
3.2.3 Global Immunity Support Ingredients Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Immunity Support Ingredients Revenue by Players
4.1.1 Global Immunity Support Ingredients Revenue by Players (2019-2024)
4.1.2 Global Immunity Support Ingredients Revenue Market Share by Players (2019-2024)
4.1.3 Global Immunity Support Ingredients Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Immunity Support Ingredients Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Immunity Support Ingredients Key Players Headquarters & Area Served
4.4 Global Immunity Support Ingredients Players, Product Type & Application
4.5 Global Immunity Support Ingredients Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Immunity Support Ingredients Market CR5 and HHI
4.6.2 Global Top 5 and 10 Immunity Support Ingredients Players Market Share by Revenue in 2023
4.6.3 2023 Immunity Support Ingredients Tier 1, Tier 2, and Tier 3
5 Immunity Support Ingredients Market Size by Type
5.1 Global Immunity Support Ingredients Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Immunity Support Ingredients Revenue by Type (2019-2030)
5.3 Global Immunity Support Ingredients Revenue Market Share by Type (2019-2030)
6 Immunity Support Ingredients Market Size by Application
6.1 Global Immunity Support Ingredients Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Immunity Support Ingredients Revenue by Application (2019-2030)
6.3 Global Immunity Support Ingredients Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 DSM
7.1.1 DSM Comapny Information
7.1.2 DSM Business Overview
7.1.3 DSM Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.1.4 DSM Immunity Support Ingredients Product Portfolio
7.1.5 DSM Recent Developments
7.2 BASF
7.2.1 BASF Comapny Information
7.2.2 BASF Business Overview
7.2.3 BASF Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.2.4 BASF Immunity Support Ingredients Product Portfolio
7.2.5 BASF Recent Developments
7.3 Zhejiang NHU
7.3.1 Zhejiang NHU Comapny Information
7.3.2 Zhejiang NHU Business Overview
7.3.3 Zhejiang NHU Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.3.4 Zhejiang NHU Immunity Support Ingredients Product Portfolio
7.3.5 Zhejiang NHU Recent Developments
7.4 Croda
7.4.1 Croda Comapny Information
7.4.2 Croda Business Overview
7.4.3 Croda Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.4.4 Croda Immunity Support Ingredients Product Portfolio
7.4.5 Croda Recent Developments
7.5 CSPC Pharma
7.5.1 CSPC Pharma Comapny Information
7.5.2 CSPC Pharma Business Overview
7.5.3 CSPC Pharma Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.5.4 CSPC Pharma Immunity Support Ingredients Product Portfolio
7.5.5 CSPC Pharma Recent Developments
7.6 EPAX
7.6.1 EPAX Comapny Information
7.6.2 EPAX Business Overview
7.6.3 EPAX Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.6.4 EPAX Immunity Support Ingredients Product Portfolio
7.6.5 EPAX Recent Developments
7.7 Adisseo
7.7.1 Adisseo Comapny Information
7.7.2 Adisseo Business Overview
7.7.3 Adisseo Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.7.4 Adisseo Immunity Support Ingredients Product Portfolio
7.7.5 Adisseo Recent Developments
7.8 Zhejiang Medicine
7.8.1 Zhejiang Medicine Comapny Information
7.8.2 Zhejiang Medicine Business Overview
7.8.3 Zhejiang Medicine Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.8.4 Zhejiang Medicine Immunity Support Ingredients Product Portfolio
7.8.5 Zhejiang Medicine Recent Developments
7.9 Raisio Group
7.9.1 Raisio Group Comapny Information
7.9.2 Raisio Group Business Overview
7.9.3 Raisio Group Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.9.4 Raisio Group Immunity Support Ingredients Product Portfolio
7.9.5 Raisio Group Recent Developments
7.10 Northeast Pharma
7.10.1 Northeast Pharma Comapny Information
7.10.2 Northeast Pharma Business Overview
7.10.3 Northeast Pharma Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.10.4 Northeast Pharma Immunity Support Ingredients Product Portfolio
7.10.5 Northeast Pharma Recent Developments
7.11 Shandong Luwei
7.11.1 Shandong Luwei Comapny Information
7.11.2 Shandong Luwei Business Overview
7.11.3 Shandong Luwei Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.11.4 Shandong Luwei Immunity Support Ingredients Product Portfolio
7.11.5 Shandong Luwei Recent Developments
7.12 Allied Biotech
7.12.1 Allied Biotech Comapny Information
7.12.2 Allied Biotech Business Overview
7.12.3 Allied Biotech Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.12.4 Allied Biotech Immunity Support Ingredients Product Portfolio
7.12.5 Allied Biotech Recent Developments
7.13 Cargill
7.13.1 Cargill Comapny Information
7.13.2 Cargill Business Overview
7.13.3 Cargill Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.13.4 Cargill Immunity Support Ingredients Product Portfolio
7.13.5 Cargill Recent Developments
7.14 Anhui Tiger
7.14.1 Anhui Tiger Comapny Information
7.14.2 Anhui Tiger Business Overview
7.14.3 Anhui Tiger Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.14.4 Anhui Tiger Immunity Support Ingredients Product Portfolio
7.14.5 Anhui Tiger Recent Developments
7.15 Shandong Tianli
7.15.1 Shandong Tianli Comapny Information
7.15.2 Shandong Tianli Business Overview
7.15.3 Shandong Tianli Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.15.4 Shandong Tianli Immunity Support Ingredients Product Portfolio
7.15.5 Shandong Tianli Recent Developments
7.16 Kerry
7.16.1 Kerry Comapny Information
7.16.2 Kerry Business Overview
7.16.3 Kerry Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.16.4 Kerry Immunity Support Ingredients Product Portfolio
7.16.5 Kerry Recent Developments
7.17 Dohler
7.17.1 Dohler Comapny Information
7.17.2 Dohler Business Overview
7.17.3 Dohler Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.17.4 Dohler Immunity Support Ingredients Product Portfolio
7.17.5 Dohler Recent Developments
7.18 Kemin
7.18.1 Kemin Comapny Information
7.18.2 Kemin Business Overview
7.18.3 Kemin Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.18.4 Kemin Immunity Support Ingredients Product Portfolio
7.18.5 Kemin Recent Developments
7.19 Chenguang Biotech
7.19.1 Chenguang Biotech Comapny Information
7.19.2 Chenguang Biotech Business Overview
7.19.3 Chenguang Biotech Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.19.4 Chenguang Biotech Immunity Support Ingredients Product Portfolio
7.19.5 Chenguang Biotech Recent Developments
7.20 FMC
7.20.1 FMC Comapny Information
7.20.2 FMC Business Overview
7.20.3 FMC Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.20.4 FMC Immunity Support Ingredients Product Portfolio
7.20.5 FMC Recent Developments
7.21 Chr. Hansen
7.21.1 Chr. Hansen Comapny Information
7.21.2 Chr. Hansen Business Overview
7.21.3 Chr. Hansen Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.21.4 Chr. Hansen Immunity Support Ingredients Product Portfolio
7.21.5 Chr. Hansen Recent Developments
7.22 Excelvite
7.22.1 Excelvite Comapny Information
7.22.2 Excelvite Business Overview
7.22.3 Excelvite Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.22.4 Excelvite Immunity Support Ingredients Product Portfolio
7.22.5 Excelvite Recent Developments
7.23 DDW
7.23.1 DDW Comapny Information
7.23.2 DDW Business Overview
7.23.3 DDW Immunity Support Ingredients Revenue and Gross Margin (2019-2024)
7.23.4 DDW Immunity Support Ingredients Product Portfolio
7.23.5 DDW Recent Developments
8 North America
8.1 North America Immunity Support Ingredients Revenue (2019-2030)
8.2 North America Immunity Support Ingredients Revenue by Type (2019-2030)
8.2.1 North America Immunity Support Ingredients Revenue by Type (2019-2024)
8.2.2 North America Immunity Support Ingredients Revenue by Type (2025-2030)
8.3 North America Immunity Support Ingredients Revenue Share by Type (2019-2030)
8.4 North America Immunity Support Ingredients Revenue by Application (2019-2030)
8.4.1 North America Immunity Support Ingredients Revenue by Application (2019-2024)
8.4.2 North America Immunity Support Ingredients Revenue by Application (2025-2030)
8.5 North America Immunity Support Ingredients Revenue Share by Application (2019-2030)
8.6 North America Immunity Support Ingredients Revenue by Country
8.6.1 North America Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Immunity Support Ingredients Revenue by Country (2019-2024)
8.6.3 North America Immunity Support Ingredients Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Immunity Support Ingredients Revenue (2019-2030)
9.2 Europe Immunity Support Ingredients Revenue by Type (2019-2030)
9.2.1 Europe Immunity Support Ingredients Revenue by Type (2019-2024)
9.2.2 Europe Immunity Support Ingredients Revenue by Type (2025-2030)
9.3 Europe Immunity Support Ingredients Revenue Share by Type (2019-2030)
9.4 Europe Immunity Support Ingredients Revenue by Application (2019-2030)
9.4.1 Europe Immunity Support Ingredients Revenue by Application (2019-2024)
9.4.2 Europe Immunity Support Ingredients Revenue by Application (2025-2030)
9.5 Europe Immunity Support Ingredients Revenue Share by Application (2019-2030)
9.6 Europe Immunity Support Ingredients Revenue by Country
9.6.1 Europe Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Immunity Support Ingredients Revenue by Country (2019-2024)
9.6.3 Europe Immunity Support Ingredients Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Immunity Support Ingredients Revenue (2019-2030)
10.2 China Immunity Support Ingredients Revenue by Type (2019-2030)
10.2.1 China Immunity Support Ingredients Revenue by Type (2019-2024)
10.2.2 China Immunity Support Ingredients Revenue by Type (2025-2030)
10.3 China Immunity Support Ingredients Revenue Share by Type (2019-2030)
10.4 China Immunity Support Ingredients Revenue by Application (2019-2030)
10.4.1 China Immunity Support Ingredients Revenue by Application (2019-2024)
10.4.2 China Immunity Support Ingredients Revenue by Application (2025-2030)
10.5 China Immunity Support Ingredients Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Immunity Support Ingredients Revenue (2019-2030)
11.2 Asia Immunity Support Ingredients Revenue by Type (2019-2030)
11.2.1 Asia Immunity Support Ingredients Revenue by Type (2019-2024)
11.2.2 Asia Immunity Support Ingredients Revenue by Type (2025-2030)
11.3 Asia Immunity Support Ingredients Revenue Share by Type (2019-2030)
11.4 Asia Immunity Support Ingredients Revenue by Application (2019-2030)
11.4.1 Asia Immunity Support Ingredients Revenue by Application (2019-2024)
11.4.2 Asia Immunity Support Ingredients Revenue by Application (2025-2030)
11.5 Asia Immunity Support Ingredients Revenue Share by Application (2019-2030)
11.6 Asia Immunity Support Ingredients Revenue by Country
11.6.1 Asia Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Immunity Support Ingredients Revenue by Country (2019-2024)
11.6.3 Asia Immunity Support Ingredients Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Immunity Support Ingredients Revenue (2019-2030)
12.2 MEALA Immunity Support Ingredients Revenue by Type (2019-2030)
12.2.1 MEALA Immunity Support Ingredients Revenue by Type (2019-2024)
12.2.2 MEALA Immunity Support Ingredients Revenue by Type (2025-2030)
12.3 MEALA Immunity Support Ingredients Revenue Share by Type (2019-2030)
12.4 MEALA Immunity Support Ingredients Revenue by Application (2019-2030)
12.4.1 MEALA Immunity Support Ingredients Revenue by Application (2019-2024)
12.4.2 MEALA Immunity Support Ingredients Revenue by Application (2025-2030)
12.5 MEALA Immunity Support Ingredients Revenue Share by Application (2019-2030)
12.6 MEALA Immunity Support Ingredients Revenue by Country
12.6.1 MEALA Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Immunity Support Ingredients Revenue by Country (2019-2024)
12.6.3 MEALA Immunity Support Ingredients Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Immunity Support Ingredients Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Vitamin C Major Manufacturers
Table 2. Vitamin E Major Manufacturers
Table 3. Other Vitamins Major Manufacturers
Table 4. Beta Glucans Major Manufacturers
Table 5. Carotenoids Major Manufacturers
Table 6. Phytosterols Major Manufacturers
Table 7. Omega-3 Fatty Acids Major Manufacturers
Table 8. Global Immunity Support Ingredients Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 9. Nutrition Supplements Major Manufacturers
Table 10. Foods & Beverages Major Manufacturers
Table 11. Pharmaceuticals Major Manufacturers
Table 12. Feeds Major Manufacturers
Table 13. Pet Foods Major Manufacturers
Table 14. Personal Care Products Major Manufacturers
Table 15. Immunity Support Ingredients Industry Trends
Table 16. Immunity Support Ingredients Industry Drivers
Table 17. Immunity Support Ingredients Industry Opportunities and Challenges
Table 18. Immunity Support Ingredients Industry Restraints
Table 19. Global Immunity Support Ingredients Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 20. Global Immunity Support Ingredients Market Size by Region (2019-2024) & (US$ Million)
Table 21. Global Immunity Support Ingredients Market Share by Region (2019-2024)
Table 22. Global Immunity Support Ingredients Market Size by Region (2025-2030) & (US$ Million)
Table 23. Global Immunity Support Ingredients Market Share by Region (2025-2030)
Table 24. Global Immunity Support Ingredients Revenue by Players (US$ Million) & (2019-2024)
Table 25. Global Immunity Support Ingredients Revenue Market Share by Players (2019-2024)
Table 26. Global Immunity Support Ingredients Key Players Ranking, 2022 VS 2023 VS 2024
Table 27. Global Immunity Support Ingredients Key Players Headquarters & Area Served
Table 28. Global Immunity Support Ingredients Players, Product Type & Application
Table 29. Global Immunity Support Ingredients Players Commercialization Time
Table 30. Global Players Market Concentration Ratio (CR5 and HHI)
Table 31. Global Immunity Support Ingredients by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Immunity Support Ingredients Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Immunity Support Ingredients Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Immunity Support Ingredients Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Immunity Support Ingredients Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 36. Global Immunity Support Ingredients Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 37. Global Immunity Support Ingredients Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Immunity Support Ingredients Revenue by Application (2019-2024) & (US$ Million)
Table 39. Global Immunity Support Ingredients Revenue by Application (2025-2030) & (US$ Million)
Table 40. Global Immunity Support Ingredients Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 41. Global Immunity Support Ingredients Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 42. DSM Company Information
Table 43. DSM Business Overview
Table 44. DSM Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 45. DSM Immunity Support Ingredients Product Portfolio
Table 46. DSM Recent Development
Table 47. BASF Company Information
Table 48. BASF Business Overview
Table 49. BASF Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 50. BASF Immunity Support Ingredients Product Portfolio
Table 51. BASF Recent Development
Table 52. Zhejiang NHU Company Information
Table 53. Zhejiang NHU Business Overview
Table 54. Zhejiang NHU Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 55. Zhejiang NHU Immunity Support Ingredients Product Portfolio
Table 56. Zhejiang NHU Recent Development
Table 57. Croda Company Information
Table 58. Croda Business Overview
Table 59. Croda Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 60. Croda Immunity Support Ingredients Product Portfolio
Table 61. Croda Recent Development
Table 62. CSPC Pharma Company Information
Table 63. CSPC Pharma Business Overview
Table 64. CSPC Pharma Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 65. CSPC Pharma Immunity Support Ingredients Product Portfolio
Table 66. CSPC Pharma Recent Development
Table 67. EPAX Company Information
Table 68. EPAX Business Overview
Table 69. EPAX Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 70. EPAX Immunity Support Ingredients Product Portfolio
Table 71. EPAX Recent Development
Table 72. Adisseo Company Information
Table 73. Adisseo Business Overview
Table 74. Adisseo Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 75. Adisseo Immunity Support Ingredients Product Portfolio
Table 76. Adisseo Recent Development
Table 77. Zhejiang Medicine Company Information
Table 78. Zhejiang Medicine Business Overview
Table 79. Zhejiang Medicine Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 80. Zhejiang Medicine Immunity Support Ingredients Product Portfolio
Table 81. Zhejiang Medicine Recent Development
Table 82. Raisio Group Company Information
Table 83. Raisio Group Business Overview
Table 84. Raisio Group Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 85. Raisio Group Immunity Support Ingredients Product Portfolio
Table 86. Raisio Group Recent Development
Table 87. Northeast Pharma Company Information
Table 88. Northeast Pharma Business Overview
Table 89. Northeast Pharma Immunity Support Ingredients Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 90. Northeast Pharma Immunity Support Ingredients Product Portfolio
Table 91. Northeast Pharma Recent Development
Table 92. Shandong Luwei Company Information
Table 93. Shandong Luwei Business Overview
Table 94. Shandong Luwei Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Shandong Luwei Immunity Support Ingredients Product Portfolio
Table 96. Shandong Luwei Recent Development
Table 97. Allied Biotech Company Information
Table 98. Allied Biotech Business Overview
Table 99. Allied Biotech Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Allied Biotech Immunity Support Ingredients Product Portfolio
Table 101. Allied Biotech Recent Development
Table 102. Cargill Company Information
Table 103. Cargill Business Overview
Table 104. Cargill Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Cargill Immunity Support Ingredients Product Portfolio
Table 106. Cargill Recent Development
Table 107. Anhui Tiger Company Information
Table 108. Anhui Tiger Business Overview
Table 109. Anhui Tiger Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Anhui Tiger Immunity Support Ingredients Product Portfolio
Table 111. Anhui Tiger Recent Development
Table 112. Shandong Tianli Company Information
Table 113. Shandong Tianli Business Overview
Table 114. Shandong Tianli Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Shandong Tianli Immunity Support Ingredients Product Portfolio
Table 116. Shandong Tianli Recent Development
Table 117. Kerry Company Information
Table 118. Kerry Business Overview
Table 119. Kerry Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Kerry Immunity Support Ingredients Product Portfolio
Table 121. Kerry Recent Development
Table 122. Dohler Company Information
Table 123. Dohler Business Overview
Table 124. Dohler Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Dohler Immunity Support Ingredients Product Portfolio
Table 126. Dohler Recent Development
Table 127. Kemin Company Information
Table 128. Kemin Business Overview
Table 129. Kemin Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Kemin Immunity Support Ingredients Product Portfolio
Table 131. Kemin Recent Development
Table 132. Chenguang Biotech Company Information
Table 133. Chenguang Biotech Business Overview
Table 134. Chenguang Biotech Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Chenguang Biotech Immunity Support Ingredients Product Portfolio
Table 136. Chenguang Biotech Recent Development
Table 137. FMC Company Information
Table 138. FMC Business Overview
Table 139. FMC Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. FMC Immunity Support Ingredients Product Portfolio
Table 141. FMC Recent Development
Table 142. Chr. Hansen Company Information
Table 143. Chr. Hansen Business Overview
Table 144. Chr. Hansen Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Chr. Hansen Immunity Support Ingredients Product Portfolio
Table 146. Chr. Hansen Recent Development
Table 147. Excelvite Company Information
Table 148. Excelvite Business Overview
Table 149. Excelvite Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Excelvite Immunity Support Ingredients Product Portfolio
Table 151. Excelvite Recent Development
Table 152. DDW Company Information
Table 153. DDW Business Overview
Table 154. DDW Immunity Support Ingredients Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. DDW Immunity Support Ingredients Product Portfolio
Table 156. DDW Recent Development
Table 157. North America Immunity Support Ingredients Revenue by Type (2019-2024) & (US$ Million)
Table 158. North America Immunity Support Ingredients Revenue by Application (2019-2024) & (US$ Million)
Table 159. North America Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 160. North America Immunity Support Ingredients Revenue by Country (2019-2024) & (US$ Million)
Table 161. North America Immunity Support Ingredients Revenue by Country (2025-2030) & (US$ Million)
Table 162. Europe Immunity Support Ingredients Revenue by Type (2019-2024) & (US$ Million)
Table 163. Europe Immunity Support Ingredients Revenue by Application (2019-2024) & (US$ Million)
Table 164. Europe Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 165. Europe Immunity Support Ingredients Revenue by Country (2019-2024) & (US$ Million)
Table 166. Europe Immunity Support Ingredients Revenue by Country (2025-2030) & (US$ Million)
Table 167. China Immunity Support Ingredients Revenue by Type (2019-2024) & (US$ Million)
Table 168. China Immunity Support Ingredients Revenue by Application (2019-2024) & (US$ Million)
Table 169. Asia Immunity Support Ingredients Revenue by Type (2019-2024) & (US$ Million)
Table 170. Asia Immunity Support Ingredients Revenue by Application (2019-2024) & (US$ Million)
Table 171. Asia Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 172. Asia Immunity Support Ingredients Revenue by Country (2019-2024) & (US$ Million)
Table 173. Asia Immunity Support Ingredients Revenue by Country (2025-2030) & (US$ Million)
Table 174. MEALA Immunity Support Ingredients Revenue by Type (2019-2024) & (US$ Million)
Table 175. MEALA Immunity Support Ingredients Revenue by Application (2019-2024) & (US$ Million)
Table 176. MEALA Immunity Support Ingredients Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 177. MEALA Immunity Support Ingredients Revenue by Country (2019-2024) & (US$ Million)
Table 178. MEALA Immunity Support Ingredients Revenue by Country (2025-2030) & (US$ Million)
Table 179. Research Programs/Design for This Report
Table 180. Authors List of This Report
Table 181. Secondary Sources
Table 182. Primary Sources
List of Figures
Figure 1. Immunity Support Ingredients Product Picture
Figure 2. Global Immunity Support Ingredients Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Immunity Support Ingredients Market Size Share 2019 VS 2023 VS 2030
Figure 4. Vitamin C Picture
Figure 5. Vitamin E Picture
Figure 6. Other Vitamins Picture
Figure 7. Beta Glucans Picture
Figure 8. Carotenoids Picture
Figure 9. Phytosterols Picture
Figure 10. Omega-3 Fatty Acids Picture
Figure 11. Global Immunity Support Ingredients Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Immunity Support Ingredients Market Size Share 2019 VS 2023 VS 2030
Figure 13. Nutrition Supplements Picture
Figure 14. Foods & Beverages Picture
Figure 15. Pharmaceuticals Picture
Figure 16. Feeds Picture
Figure 17. Pet Foods Picture
Figure 18. Personal Care Products Picture
Figure 19. Global Immunity Support Ingredients Market Size (US$ Million) & (2019-2030)
Figure 20. Global Immunity Support Ingredients Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Immunity Support Ingredients Market Share by Region: 2019 VS 2023 VS 2030
Figure 22. Global Immunity Support Ingredients Players Revenue Share Top 10 and Top 5 in 2023
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global Immunity Support Ingredients Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Immunity Support Ingredients Revenue Market Share 2019 VS 2023 VS 2030
Figure 26. Global Immunity Support Ingredients Revenue Market Share by Type (2019-2030)
Figure 27. Global Immunity Support Ingredients Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Immunity Support Ingredients Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 29. Global Immunity Support Ingredients Revenue Market Share by Application (2019-2030)
Figure 30. North America Immunity Support Ingredients Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. North America Immunity Support Ingredients Revenue by Type (2025-2030) & (US$ Million)
Figure 32. North America Immunity Support Ingredients Revenue Share by Type (2019-2030)
Figure 33. North America Immunity Support Ingredients Revenue by Application (2025-2030) & (US$ Million)
Figure 34. North America Immunity Support Ingredients Revenue Share by Application (2019-2030)
Figure 35. North America Immunity Support Ingredients Revenue Share by Country (2019-2030)
Figure 36. United States Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. Canada Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. Europe Immunity Support Ingredients Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 39. Europe Immunity Support Ingredients Revenue by Type (2025-2030) & (US$ Million)
Figure 40. Europe Immunity Support Ingredients Revenue Share by Type (2019-2030)
Figure 41. Europe Immunity Support Ingredients Revenue by Application (2025-2030) & (US$ Million)
Figure 42. Europe Immunity Support Ingredients Revenue Share by Application (2019-2030)
Figure 43. Europe Immunity Support Ingredients Revenue Share by Country (2019-2030)
Figure 44. Germany Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 45. France Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 46. U.K. Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 47. Italy Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 48. Russia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 49. Nordic Countries Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 50. China Immunity Support Ingredients Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 51. China Immunity Support Ingredients Revenue by Type (2025-2030) & (US$ Million)
Figure 52. China Immunity Support Ingredients Revenue Share by Type (2019-2030)
Figure 53. China Immunity Support Ingredients Revenue by Application (2025-2030) & (US$ Million)
Figure 54. China Immunity Support Ingredients Revenue Share by Application (2019-2030)
Figure 55. Asia Immunity Support Ingredients Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 56. Asia Immunity Support Ingredients Revenue by Type (2025-2030) & (US$ Million)
Figure 57. Asia Immunity Support Ingredients Revenue Share by Type (2019-2030)
Figure 58. Asia Immunity Support Ingredients Revenue by Application (2025-2030) & (US$ Million)
Figure 59. Asia Immunity Support Ingredients Revenue Share by Application (2019-2030)
Figure 60. Asia Immunity Support Ingredients Revenue Share by Country (2019-2030)
Figure 61. Japan Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 62. South Korea Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 63. India Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 64. Australia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 65. China Taiwan Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. Southeast Asia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. MEALA Immunity Support Ingredients Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 68. MEALA Immunity Support Ingredients Revenue by Type (2025-2030) & (US$ Million)
Figure 69. MEALA Immunity Support Ingredients Revenue Share by Type (2019-2030)
Figure 70. MEALA Immunity Support Ingredients Revenue by Application (2025-2030) & (US$ Million)
Figure 71. MEALA Immunity Support Ingredients Revenue Share by Application (2019-2030)
Figure 72. MEALA Immunity Support Ingredients Revenue Share by Country (2019-2030)
Figure 73. Mexico Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. South Korea Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Brazil Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Israel Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 77. Argentina Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 78. Colombia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 79. Turkey Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 80. Saudi Arabia Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 81. UAE Immunity Support Ingredients Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 82. Years Considered
Figure 83. Research Process
Figure 84. Key Executives Interviewed
